Treace Medical Concepts (TMCI) Cash from Operations (2020 - 2026)

Treace Medical Concepts has reported Cash from Operations for 7 years, with the latest figure at 7240000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 72.46% year-over-year to 7240000.0; the trailing twelve-month figure through Mar 2026 stood at 12928000.0 (up 49.79% YoY), and the FY2025 full-year result was 15970000.0, up 57.03% from the prior year.
• Cash from Operations for Q1 2026 stood at 7240000.0, up from 8026000.0 in the prior quarter.
• The five-year high for Cash from Operations was 7240000.0 in Q1 2026, with the low at 17259000.0 in Q1 2023.
• Historically, Cash from Operations has averaged 6536470.59 across 5 years, with a median of 7490000.0 in 2022.
• Annual changes were most pronounced in 2022 — Cash from Operations tumbled 1523.54% — and 2025, when it surged 158.14%.
• Treace Medical Concepts' Cash from Operations stood at 5358000.0 in 2022, then soared by 109.93% to 532000.0 in 2023, then plunged by 890.79% to 4207000.0 in 2024, then plunged by 90.78% to 8026000.0 in 2025, then soared by 190.21% to 7240000.0 in 2026.
• The last three Cash from Operations figures came in at 7240000.0 (Q1 2026), 8026000.0 (Q4 2025), and 9092000.0 (Q3 2025), per Business Quant data.